Articles From: Novo Banco Has Four Potential Buyers to NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc


2014/12/29
Novo Banco, the Portuguese bank created out of failed lender Banco Espírito Santo SA in August, has received at least four expressions of interest from potential buyers before a Dec.
Sign-up for Novo Banco Has Four Potential Buyers investment picks
BAGSVAERD, Denmark, Jan.
Sign-up for Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares investment picks
2014/12/16
SYDNEY , Dec.
Sign-up for Novogen Announces Breakthrough Discovery in the Treatment of Melanoma investment picks
2015/1/15
SYDNEY , Jan.
Sign-up for Novogen Announces Important Discovery in Regenerative Medicine Program investment picks
2014/12/15
SYDNEY , Dec.
Sign-up for Novogen Provides Update On Progress Of Cantrixil Into The Clinic investment picks
2014/12/17
SYDNEY , Dec.
Sign-up for Novogen Raises A$4.1m In Private Placement to US Institutions investment picks
2015/1/7
-- 2015/2016 clinical research strategy to be previewed --
Sign-up for Novogen to Conduct Shareholder/Investor Briefing in New York investment picks
NOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss fourth quarter and full year 2014 earnings on Monday, February 23, 2015 at 8:00 am (US Central Time). Financial results for the fourth quarter and full year ending on December 31, 2014 are expected to be released that morning before the market opens.
Sign-up for NOW Inc. Announces Fourth Quarter and 2014 Earnings Conference Call investment picks
NOW Inc. (NYSE: DNOW) reported that for its third quarter ended September 30, 2014 it earned net income of $32 million, or $0.30 per fully diluted share, compared to second quarter ended June 30, 2014 net income of $27 million, or $0.25 per fully diluted share.
Sign-up for NOW Inc. Announces Third Quarter 2014 Earnings investment picks
With the seasons changing, now is the time to secure homes against freezing pipes, according to American Water Resources , the exclusive provider of service line protection programs for the Department of Environmental Protection (DEP) in providing Service Line Protection to New York City customers.
Sign-up for Now is the Best Time to Winterize Homes investment picks
2014/12/17
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens Traders have spent much of 2014 kvetching about a lack of volatility in the market.
Sign-up for Now it's the Fed's turn to pour grease on the market fire investment picks
2015/1/21
Chef Michael Mina's newest concept celebrates a renaissance of French technique LAS VEGAS , Jan.
Sign-up for Now Open: BARDOT Brasserie At ARIA Entices Las Vegas With Haute Parisian Cuisine investment picks
2014/11/6
The fast casual segment remains the top performer in the restaurant sector, and will continue to lead activity and change.
Sign-up for Now Serving Growth in the Restaurant Sector investment picks
Chipotle Mexican Grill (NYSE: CMG) launched a new web-based mobile job application program for smart phones and tablets to allow job applicants to apply using their mobile devices.
Sign-up for Now You Can Apply at Chipotle with Your Mobile Device investment picks
2014/12/15
By Wallace Witkowski, MarketWatch Timing the bottom, however, can be tricky, firms admit.
Sign-up for Now's time to consider energy stocks: Goldman Sachs, Morgan Stanley investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) breached their fiduciary duties in connection with the planned merger of the Company with Shire plc.
Sign-up for NPS PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of NPS Pharmaceuticals, Inc. to Shire plc investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced the appointment of Pierre Legault, MBA, CA, CPA to its board of directors.
Sign-up for NPS Pharma Appoints Pierre Legault to Board of Directors investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its results for the quarter ended September 30, 2014.
Sign-up for NPS Pharma Reports Third-Quarter 2014 Financial Results investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the 2014 Deutsche Bank BioFEST Conference in Boston on Tuesday, December 2, 2014 at 9:55 a.m. ET.
Sign-up for NPS Pharma to Present at Deutsche Bank BioFEST Conference investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the 33 rd Annual J.
Sign-up for NPS Pharma to Present at J.P. Morgan Healthcare Conference investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Jefferies 2014 Global Healthcare Conference in London on Thursday, November 20, 2014 at 8:00 a.m. WET.
Sign-up for NPS Pharma to Present at Jefferies Global Healthcare Conference investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Oppenheimer 25 th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 9:45 a.m. ET.
Sign-up for NPS Pharma to Present at Oppenheimer Healthcare Conference investment picks
NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its third quarter 2014 financial results on Monday, November 10, 2014 at approximately 4:00 p.m. ET.
Sign-up for NPS Pharma to Report Third Quarter 2014 Financial Results investment picks
2015/1/12
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of NPS Pharmaceuticals Inc. (“NPS”) (NasdaqGS: NPSP) concerning the sale to Shire PLC.
Sign-up for NPS PHARMACEUTICALS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Shire PLC investment picks
2015/1/5
By Jonathan D.
Sign-up for NPS Pharmaceuticals Seeks Buyer -- Update investment picks
2015/1/12
NEW YORK , Jan.
Sign-up for NPS Pharmaceuticals, Inc. Acquisition By Shire Plc May Not Be In The Best Interests Of NPSP Shareholders investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc. NEW YORK , Jan.
Sign-up for NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Shire Plc - NPSP investment picks
2015/1/12
WILMINGTON, Del.
Sign-up for NPS PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2015/1/14
Levi & Korsinsky is investigating the Board of Directors of NPS Pharmaceuticals Inc. (“NPS Pharmaceuticals” or “the Company”) (NASDAQGS: NPSP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Shire plc.
Sign-up for NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Novo Banco Has Four Potential Buyers to NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent